These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

384 related items for PubMed ID: 15238081

  • 1. Antinucleosome autoantibodies bind directly to cell lines in vitro and via the FcgammaRIIB receptor to B lymphocytes in vivo: a role for immune complexes in interactions between antinucleosome IgG2a and B cells of BXSB lupus mice.
    Li X, Egorina E, Bertelsen EL, Dahlen H, Hannestad K.
    Scand J Immunol; 2004; 60(1-2):121-33. PubMed ID: 15238081
    [Abstract] [Full Text] [Related]

  • 2. Specificity of monoclonal anti-nucleosome auto-antibodies derived from lupus mice.
    Kramers K, Stemmer C, Monestier M, van Bruggen MC, Rijke-Schilder TP, Hylkema MN, Smeenk RJ, Muller S, Berden JH.
    J Autoimmun; 1996 Dec; 9(6):723-9. PubMed ID: 9115574
    [Abstract] [Full Text] [Related]

  • 3. Structural characterization of an (NZB x NZW)F1 mouse-derived IgM monoclonal antibody that binds through V region-dependent interactions to murine IgG anti-DNA antibodies.
    Margaritte C, Gilbert D, Brard F, Tron F.
    J Autoimmun; 1994 Dec; 7(6):711-25. PubMed ID: 7888030
    [Abstract] [Full Text] [Related]

  • 4. [Role of the nucleosome in the physiopathology of systemic lupus erythematosus].
    Amoura Z, Piette JC.
    Ann Med Interne (Paris); 2003 Feb; 154(1):25-32. PubMed ID: 12746656
    [Abstract] [Full Text] [Related]

  • 5. Treatment of lupus-prone NZB/NZW F1 mice with recombinant soluble Fc gamma receptor II (CD32).
    Werwitzke S, Trick D, Sondermann P, Kamino K, Schlegelberger B, Kniesch K, Tiede A, Jacob U, Schmidt RE, Witte T.
    Ann Rheum Dis; 2008 Feb; 67(2):154-61. PubMed ID: 17557887
    [Abstract] [Full Text] [Related]

  • 6. Binding of nucleosomes to a cell surface receptor: redistribution and endocytosis in the presence of lupus antibodies.
    Koutouzov S, Cabrespines A, Amoura Z, Chabre H, Lotton C, Bach JF.
    Eur J Immunol; 1996 Feb; 26(2):472-86. PubMed ID: 8617320
    [Abstract] [Full Text] [Related]

  • 7. Fcgamma receptor-dependent expansion of a hyperactive monocyte subset in lupus-prone mice.
    Santiago-Raber ML, Amano H, Amano E, Baudino L, Otani M, Lin Q, Nimmerjahn F, Verbeek JS, Ravetch JV, Takasaki Y, Hirose S, Izui S.
    Arthritis Rheum; 2009 Aug; 60(8):2408-17. PubMed ID: 19644866
    [Abstract] [Full Text] [Related]

  • 8. Plasma levels of nucleosomes and nucleosome-autoantibody complexes in murine lupus: effects of disease progression and lipopolyssacharide administration.
    Licht R, van Bruggen MC, Oppers-Walgreen B, Rijke TP, Berden JH.
    Arthritis Rheum; 2001 Jun; 44(6):1320-30. PubMed ID: 11407691
    [Abstract] [Full Text] [Related]

  • 9. B cell apoptosis accelerates the onset of murine lupus.
    Trébéden-Nègre H, Weill B, Fournier C, Batteux F.
    Eur J Immunol; 2003 Jun; 33(6):1603-12. PubMed ID: 12778478
    [Abstract] [Full Text] [Related]

  • 10. Effect of the B cell superantigen protein A from S. aureus on the early lupus disease of (NZBxNZW) F1 mice.
    Viau M, Zouali M.
    Mol Immunol; 2005 May; 42(7):849-55. PubMed ID: 15829273
    [Abstract] [Full Text] [Related]

  • 11. Selective silencing of DNA-specific B lymphocytes delays lupus activity in MRL/lpr mice.
    Tchorbanov AI, Voynova EN, Mihaylova NM, Todorov TA, Nikolova M, Yomtova VM, Chiang BL, Vassilev TL.
    Eur J Immunol; 2007 Dec; 37(12):3587-96. PubMed ID: 18034421
    [Abstract] [Full Text] [Related]

  • 12. Stable expression of a recombinant human antinucleosome antibody to investigate relationships between antibody sequence, binding properties, and pathogenicity.
    Mason LJ, Lambrianides A, Haley JD, Manson JJ, Latchman DS, Isenberg DA, Rahman A.
    Arthritis Res Ther; 2005 Dec; 7(5):R971-83. PubMed ID: 16207338
    [Abstract] [Full Text] [Related]

  • 13. Target silencing of disease-associated B-lymphocytes by chimeric molecules in SCID model of pristane-induced autoimmunity.
    Dimitrova I, Gesheva V, Nikolova K, Mihaylova N, Todorov T, Nikolova M, Tchorbanov A.
    Lupus; 2010 Oct; 19(11):1261-71. PubMed ID: 20530521
    [Abstract] [Full Text] [Related]

  • 14. Follicular exclusion of autoreactive B cells requires FcgammaRIIb.
    Paul E, Nelde A, Verschoor A, Carroll MC.
    Int Immunol; 2007 Apr; 19(4):365-73. PubMed ID: 17307801
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Anti-nucleosome antibodies and T-cell response in systemic lupus erythematosus.
    Fournel S, Muller S.
    Ann Med Interne (Paris); 2002 Dec; 153(8):513-9. PubMed ID: 12610425
    [Abstract] [Full Text] [Related]

  • 17. Antigen localization within the splenic marginal zone restores humoral immune response and IgG class switch in complement C4-deficient mice.
    Zachrau B, Finke D, Kropf K, Gosink HJ, Kirchner H, Goerg S.
    Int Immunol; 2004 Dec; 16(12):1685-90. PubMed ID: 15477230
    [Abstract] [Full Text] [Related]

  • 18. Monoclonal anti-histone autoantibodies derived from murine models of lupus.
    Kotzin BL, Lafferty JA, Portanova JP, Rubin RL, Tan EM.
    J Immunol; 1984 Nov; 133(5):2554-9. PubMed ID: 6332855
    [Abstract] [Full Text] [Related]

  • 19. Cross-reactions of anti-DNA autoantibodies with cell surface proteins.
    Raz E, Ben-Bassat H, Davidi T, Shlomai Z, Eilat D.
    Eur J Immunol; 1993 Feb; 23(2):383-90. PubMed ID: 7679642
    [Abstract] [Full Text] [Related]

  • 20. Protection against renal disease in (NZB x NZW)F(1) lupus-prone mice after somatic B cell gene vaccination with anti-DNA immunoglobulin consensus peptide.
    Ferrera F, Hahn BH, Rizzi M, Anderson M, Fitzgerald J, Millo E, Indiveri F, Shi FD, Filaci G, La Cava A.
    Arthritis Rheum; 2007 Jun; 56(6):1945-53. PubMed ID: 17530718
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.